The Treatment of Schistosomiasis Mansoni in Murang'a District, Kenya: A Double Blind Controlled Trial of Three Hycanthone Regimens and Oxamniquine

View More View Less
  • Department of Medicine, University of Nairobi, Nairobi, District Hospital, Murang'a, Division of Vector Borne Diseases, Nairobi, and Provincial Medical Headquarters, Central Province, Kenya
Restricted access

In a pilot study designed to find the most suitable drug regimen for the mass treatment of schistosomiasis mansoni, four regimens were found equally effective. Hycanthone 1.5 mg/kg body weight in a single dose was thought to be the most satisfactory regimen in the given situation. The other regimens were oxamniquine 7.5 mg/kg, hycanthone 1.5 mg/kg given on two occasions a week apart, and hycanthone 2.25 mg/kg, all by intramuscular injection.